Identification of ECI2 as Potential Prognostic Biomarkers Based on a Fatty Acid Metabolism‐Related Gene Model in Clear Cell Renal Cell Carcinoma
Genetics Research · 2025
DOI: 10.1155/genr/2237539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, 2025. Verfasst von Di Cui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fuyang Medical College, Fuyang Normal University, Fuyang 236037, Anhui, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor, Fatty Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fuyang Normal University.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC) is the most common and highly malignant subtype of renal cancer, characterized by significant lipid deposition. Research has indicated that its growth and metastasis are closely associated with fatty acid metabolism.
Methods
In this study, we integrated TCGA transcriptome data, CPTAC proteomics data, and the single‐cell dataset GSE152938 to identify differentially expressed genes related to fatty acid metabolism in ccRCC. Using the LASSO algorithm, we constructed a prognostic model based on these genes. Western blot and PCR analyses confirmed the expression levels of the ECI2 in ccRCC, while lentiviral transduction was used to investigate the effects of ECI2 expression on tumor biological behaviors.
Results
Our findings demonstrated that ECI2 expression is downregulated in ccRCC, and lower ECI2 levels correlate with better patient prognosis. Functional assays showed that overexpression of ECI2 significantly inhibited the proliferation and migration of ccRCC cells and increased their sensitivity to the chemotherapeutic drug oxaliplatin.
Conclusion
This study highlights the potential tumor‐suppressive role of ECI2 in ccRCC and suggests its viability as a diagnostic and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuyang Medical College, Fuyang Normal University, Fuyang 236037, Anhui, China.
- Clinical Laboratory, Fuyang Minsheng Hospital, Fuyang 236072, Anhui, China.
- Urology Surgery, Fuyang People's Hospital, Fuyang 236000, Anhui, China.
- Department of Health Examination Center, First People's Hospital of Nanning, Nanning 530022, Guangxi, China.
- Thoracic and Cardiovascular Surgery, Fuyang Fifth People's Hospital, Fuyang 236037, Anhui, China.
ORCID-Profile: Di Cui, Wenxu Wu, Wenjiang Yu
Förderung
- Fuyang Normal University
Zitieren
APA
Cui, D., Yang, W., Guan, B., Wu, W., & Yu, W. (2025). Identification of ECI2 as Potential Prognostic Biomarkers Based on a Fatty Acid Metabolism‐Related Gene Model in Clear Cell Renal Cell Carcinoma. Genetics Research. https://doi.org/10.1155/genr/2237539
Vancouver
Cui D, Yang W, Guan B, Wu W, Yu W. Identification of ECI2 as Potential Prognostic Biomarkers Based on a Fatty Acid Metabolism‐Related Gene Model in Clear Cell Renal Cell Carcinoma. Genetics Research. 2025. doi:10.1155/genr/2237539
BibTeX
@article{Cui2025,
author = {Cui, Di and Yang, Wenye and Guan, Bo and Wu, Wenxu and Yu, Wenjiang},
title = {Identification of ECI2 as Potential Prognostic Biomarkers Based on a Fatty Acid Metabolism‐Related Gene Model in Clear Cell Renal Cell Carcinoma},
journal = {Genetics Research},
year = {2025},
doi = {10.1155/genr/2237539}
}
EUVIMED